CASPER: A Phase I trial combining calaspargase pegol-mnkl and cobimetinib in pancreatic cancer.
Saved in:
| Title: | CASPER: A Phase I trial combining calaspargase pegol-mnkl and cobimetinib in pancreatic cancer. |
|---|---|
| Authors: | Lopez CD; Department of Medicine, Hematology and Medical Oncology, Oregon Health & Science University (OHSU), OR 97239, Portland.; Brenden-Colson Center for Pancreatic Care, Knight Cancer Institute (OHSU), OR, Portland., Kardosh A; Department of Medicine, Hematology and Medical Oncology, Oregon Health & Science University (OHSU), OR 97239, Portland.; Brenden-Colson Center for Pancreatic Care, Knight Cancer Institute (OHSU), OR, Portland., Chen EY; Department of Medicine, Hematology and Medical Oncology, Oregon Health & Science University (OHSU), OR 97239, Portland., Pegna G; Department of Medicine, Hematology and Medical Oncology, Oregon Health & Science University (OHSU), OR 97239, Portland., Guimaraes A; Brenden-Colson Center for Pancreatic Care, Knight Cancer Institute (OHSU), OR, Portland.; Department of Radiology, OHSU, OR 97239, Portland., Foster B; Department of Pathology, OHSU, OR 97239, Portland., Brinkerhoff B; Department of Pathology, OHSU, OR 97239, Portland., Goodyear SM; Department of Medicine, Hematology and Medical Oncology, Oregon Health & Science University (OHSU), OR 97239, Portland.; Brenden-Colson Center for Pancreatic Care, Knight Cancer Institute (OHSU), OR, Portland., Lim JY; Biostatistics Shared Resource, Knight Cancer Institute (OHSU)., Taber E; Department of Medicine, Hematology and Medical Oncology, Oregon Health & Science University (OHSU), OR 97239, Portland., Rajagopalan B; Department of Medicine, Hematology and Medical Oncology, Oregon Health & Science University (OHSU), OR 97239, Portland., Edmerson E; Department of Medicine, Hematology and Medical Oncology, Oregon Health & Science University (OHSU), OR 97239, Portland., Vo J; Department of Medicine, Hematology and Medical Oncology, Oregon Health & Science University (OHSU), OR 97239, Portland., Nelson K; Department of Medicine, Hematology and Medical Oncology, Oregon Health & Science University (OHSU), OR 97239, Portland., Jackson A; Department of Medicine, Hematology and Medical Oncology, Oregon Health & Science University (OHSU), OR 97239, Portland., Gingerich T; Department of Medicine, Hematology and Medical Oncology, Oregon Health & Science University (OHSU), OR 97239, Portland., Fahlman A; Department of Medicine, Hematology and Medical Oncology, Oregon Health & Science University (OHSU), OR 97239, Portland., Lessenich C; Department of Medicine, Hematology and Medical Oncology, Oregon Health & Science University (OHSU), OR 97239, Portland., Fennell F; Department of Medicine, Hematology and Medical Oncology, Oregon Health & Science University (OHSU), OR 97239, Portland., Ventura D; Department of Medicine, Hematology and Medical Oncology, Oregon Health & Science University (OHSU), OR 97239, Portland., Roy P; Department of Medicine, Hematology and Medical Oncology, Oregon Health & Science University (OHSU), OR 97239, Portland., Keith D; Brenden-Colson Center for Pancreatic Care, Knight Cancer Institute (OHSU), OR, Portland., Sheppard B; Brenden-Colson Center for Pancreatic Care, Knight Cancer Institute (OHSU), OR, Portland.; Department of Surgery, OHSU, OR 97239, Portland., Brody JR; Brenden-Colson Center for Pancreatic Care, Knight Cancer Institute (OHSU), OR, Portland.; Department of Surgery, OHSU, OR 97239, Portland., Mills GB; Brenden-Colson Center for Pancreatic Care, Knight Cancer Institute (OHSU), OR, Portland.; Precision Oncology, Knight Cancer Institute OHSU, OR 97239, Portland., Ronai ZA; Sanford Burnham Prebys, La Jolla, CA 92037, San Diego., Sears RC; Brenden-Colson Center for Pancreatic Care, Knight Cancer Institute (OHSU), OR, Portland.; Department of Molecular and Medical Genetics, OHSU, OR 97239, Portland. |
| Source: | Future oncology (London, England) [Future Oncol] 2024; Vol. 20 (37), pp. 2915-2925. Date of Electronic Publication: 2024 Oct 08. |
| Publication Type: | Clinical Trial Protocol; Journal Article |
| Journal Info: | Publisher: Taylor & Francis Country of Publication: England NLM ID: 101256629 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1744-8301 (Electronic) Linking ISSN: 14796694 NLM ISO Abbreviation: Future Oncol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
